sk&f 81297 has been researched along with morphine in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baba, J; Ichimaru, Y; Mori, T; Suzuki, T | 1 |
Ito, S; Mori, T; Sawaguchi, T | 1 |
Han, J; Liu, Y; Liu, Z; Ren, W; Wei, C; Zhang, X; Zheng, Q | 1 |
Arena, DT; Heinrichs, SC; Kaplan, GB; Kobrin, KL; Nguyen, OH | 1 |
Huang, W; Li, X; Li, Y; Liu, Q; Liu, Y; Wang, C; Wang, X; Zhang, Y; Zhao, Y | 1 |
Cao, K; Huang, W; Li, X; Li, Y; Liu, Q; Liu, Y; Wang, C; Wang, X; Xiao, R; Zhao, Y | 1 |
6 other study(ies) available for sk&f 81297 and morphine
Article | Year |
---|---|
Effects of rolipram, a selective inhibitor of phosphodiesterase 4, on hyperlocomotion induced by several abused drugs in mice.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Benzazepines; Cyclic Nucleotide Phosphodiesterases, Type 4; Dopamine Agents; Locomotion; Male; Methamphetamine; Mice; Morphine; Phencyclidine; Phosphodiesterase Inhibitors; Rolipram | 2000 |
Differential effects of micro-opioid, delta-opioid and kappa-opioid receptor agonists on dopamine receptor agonist-induced climbing behavior in mice.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Apomorphine; Benzamides; Benzazepines; Dopamine Agonists; Male; Mice; Mice, Inbred Strains; Morphine; Motor Activity; Piperazines; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Tetrahydronaphthalenes | 2006 |
Activation of the D1 receptors inhibits the long-term potentiation in vivo induced by acute morphine administration through a D1-GluN2A interaction in the nucleus accumbens.
Topics: Animals; Benzazepines; Dopamine Agonists; Excitatory Postsynaptic Potentials; Long-Term Potentiation; Male; Morphine; Narcotics; Nucleus Accumbens; Prefrontal Cortex; Quinpirole; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Synapses | 2014 |
Dopamine D1 receptor agonist treatment attenuates extinction of morphine conditioned place preference while increasing dendritic complexity in the nucleus accumbens core.
Topics: Animals; Benzazepines; Conditioning, Psychological; Dendrites; Dopamine Agonists; Dose-Response Relationship, Drug; Extinction, Psychological; Male; Mice, Inbred C57BL; Morphine; Narcotics; Nucleus Accumbens; Receptors, Dopamine D1; Reward; Spatial Behavior | 2017 |
A dopamine D1 receptor agonist improved learning and memory in morphine-treated rats.
Topics: Animals; Benzazepines; Disease Models, Animal; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Glutamate Decarboxylase; Learning Disabilities; Male; Maze Learning; Memory Disorders; Morphine; Narcotics; Periaqueductal Gray; Rats; Rats, Wistar; Receptor, trkB; Receptors, Dopamine D1 | 2018 |
Dopamine D1 receptor agonist treatment alleviates morphine-exposure-induced learning and memory impairments.
Topics: Animals; Benzazepines; Cyclic AMP-Dependent Protein Kinases; Dopamine Agonists; Dopamine Antagonists; Learning; Male; Maze Learning; Memory; Memory Disorders; Morphine; Periaqueductal Gray; Rats; Rats, Wistar; Receptors, Dopamine D1; Spatial Learning; Toll-Like Receptor 4 | 2019 |